Not applicableEnded earlyNCT05666999What this trial is testingPost-market Clinical Follow-up Study for a CE Marked Wound Care Product (FibDex®)Who this might be right forSkin Transplantation UPM-Kymmene Corporation 18
Early research (Phase 1)UnknownNCT04234750What this trial is testingMesenchymal Stem Cell-derived Pleiotropic Factor in the Treatment of Donor SitesWho this might be right forEvaluate the Safety and Effectiveness of Mesenchymal Stem Cell Conditioned Medium-derived Pleiotropic Factor in Treating Donor Sites Chinese PLA General Hospital 20
Testing effectiveness (Phase 2)UnknownNCT03091933What this trial is testingAntiminor Histocompatibility Complex (MiHA) T Cells for Patients With Relapsed Hematologic Malignancies Following Matched HSCT (Guided Lymphocyte Immunopeptide Derived Expansion)Who this might be right forHematologic CancerRelapse LeukemiaRelapsed Adult ALL+6 more Ciusss de L'Est de l'Île de Montréal 20
Not applicableEnded earlyNCT03343535What this trial is testingOCS Lung System EXPAND II TrialWho this might be right forLung Transplantation TransMedics 46
Testing effectiveness (Phase 2)Looking for participantsNCT07256210What this trial is testingFeasibility and Safety of Donor-derived NK-cell Infusions for Leukemia Relapse Prophylaxis After Hematopoietic Stem Cell TransplantationWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic T-cell LeukemiaMixed Phenotype Acute Leukemia Federal Research Institute of Pediatric Hematology, Oncology and Immunology 15
Not applicableStudy completedNCT02635347What this trial is testingRemote Ischemic Conditioning (RIC) in Recipients of Brain Death Donor Livers - A Feasibility and Safety StudyWho this might be right forLiver FailureCarcinoma, Hepatocellular Rutgers, The State University of New Jersey 31
Not applicableStudy completedNCT05194306What this trial is testingPERTRIAL - Perla® Preservation SolutionWho this might be right forOrgan TransplantIschemic Reperfusion Injury Advanced Life Solutions 11
Early research (Phase 1)Study completedNCT00509691What this trial is testingVaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to TherapyWho this might be right forCancer University of Louisville 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT01744223What this trial is testingSafety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell TransplantWho this might be right forAcute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaLymphoma+1 more Bellicum Pharmaceuticals 36
Testing effectiveness (Phase 2)Study completedNCT01974206What this trial is testingEvaluate the Efficacy and Safety of a Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seronegative Kidney Transplant Recipients Receiving an Organ From a CMV-Seropositive DonorWho this might be right forKidney Transplantation Cytomegalovirus (CMV) Negative Recipients Astellas Pharma Global Development, Inc. 150
Early research (Phase 1)UnknownNCT02957552What this trial is testingSafety and Tolerance of Immunomodulating Therapy With Donor-specific MSC in Pediatric Living-Donor Liver TransplantationWho this might be right forPediatric Liver Transplantation University Hospital Tuebingen 7
Very early researchNot Yet RecruitingNCT07706205What this trial is testingSafety and Efficacy of the Bispecific T-Cell Engager (BiTE) as Conditioning Regimen for ABO-incompatible Living Donor Kidney TransplantationWho this might be right forABO Blood Type Incompatible Kidney Transplantation West China Hospital 20
Very early researchLooking for participantsNCT06793241What this trial is testingDonor Derived CD19 CAR-T Cells in the Treatment of R/R B-cell Acute Lymphoblastic LeukemiaWho this might be right forB-cell Acute Lymphoblastic Leukemia Zhejiang University 15
Testing effectiveness (Phase 2)Study completedNCT01413568What this trial is testingSafety and Efficacy of POL6326 for Mobilization/Transplant of Sibling Donor in Patients With Hematologic MalignanciesWho this might be right forAcute Myeloid Leukemia in RemissionAdult Acute Lymphoblastic Leukemia in RemissionChronic Myelogenous Leukemia (CML)+5 more Polyphor Ltd. 38
Testing effectiveness (Phase 2)UnknownNCT02563340What this trial is testingEffect of BM-MSCs on Chronic AMR After Kidney TransplantationWho this might be right forKidney Transplantation First Affiliated Hospital, Sun Yat-Sen University 60
Early research (Phase 1)Ended earlyNCT02295501What this trial is testingA Prospective, Open Label, Phase 1 Safety Study of Passive Immune Therapy During Acute Ebola Virus Disease Using Transfusion of INTERCEPT Plasma Prepared From Volunteer Donors Who Have Recovered From Ebola Virus DiseaseWho this might be right forAcute Ebola Virus Disease Cerus Corporation 6
Early research (Phase 1)UnknownNCT01991301What this trial is testingCarfilzomib for the Prevention of Graft Versus Host DiseaseWho this might be right forGraft-versus-host Disease Sheba Medical Center 30
Not applicableStudy completedNCT02424006What this trial is testingSafety and Effectiveness of the RHCIII-MPC Biosynthetic Cornea in Patients Requiring Anterior Lamellar KeratoplastyWho this might be right forLeukoma L.V. Prasad Eye Institute 2
Large-scale testing (Phase 3)Study completedNCT00195273What this trial is testingStudy Evaluating Sirolimus in Kidney Transplant RecipientsWho this might be right forGraft vs Host DiseaseKidney Transplantation Wyeth is now a wholly owned subsidiary of Pfizer 61
Testing effectiveness (Phase 2)Study completedNCT00570245What this trial is testingSafety and Efficacy Study of Nitric Oxide in Patients Going Through Lung TransplantationWho this might be right forLung Transplantation Mallinckrodt 49